Development and pilot testing of a leaflet informing women with breast cancer about genomic testing for polygenic risk

Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers

(2017) Karoline B. Kuchenbaecker et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Association analysis identifies 65 new breast cancer risk loci

(2017) Kyriaki Michailidou et al.   NATURE

Polygenic risk score is associated with increased disease risk in 52 Finnish breast cancer families

(2016) Taru A. Muranen et al.   BREAST CANCER RESEARCH AND TREATMENT

Breast cancer risk prediction using a polygenic risk score in the familial setting: a prospective study from the Breast Cancer Family Registry and kConFab

(2016) Hongyan Li et al.   GENETICS IN MEDICINE

Breast Cancer Risk Prediction Using Clinical Models and 77 Independent Risk-Associated SNPs for Women Aged Under 50 Years: Australian Breast Cancer Family Registry

(2015) G. S. Dite et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Prediction of Breast Cancer Risk Based on Profiling With Common Genetic Variants

(2015) Nasim Mavaddat et al.   JNCI-Journal of the National Cancer Institute

Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer

(2015) Kyriaki Michailidou et al.   NATURE GENETICS

Prediction of Breast Cancer Risk Based on Profiling With Common Genetic Variants

(2015) Nasim Mavaddat et al.   JNCI-Journal of the National Cancer Institute

Large-scale genotyping identifies 41 new loci associated with breast cancer risk

(2013) Kyriaki Michailidou et al.   NATURE GENETICS

A Role for Common Genomic Variants in the Assessment of Familial Breast Cancer

(2012) Sarah Sawyer et al.   JOURNAL OF CLINICAL ONCOLOGY

Essential Elements of Genetic Cancer Risk Assessment, Counseling, and Testing: Updated Recommendations of the National Society of Genetic Counselors

(2011) Bronson D. Riley et al.   Journal of Genetic Counseling

Association of Risk-Reducing Surgery in BRCA1 or BRCA2 Mutation Carriers With Cancer Risk and Mortality

(2010) Susan M. Domchek   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Development and pilot testing of an online screening decision aid for men with a family history of prostate cancer

(2010) Claire E. Wakefield et al.   PATIENT EDUCATION AND COUNSELING

American Society of Clinical Oncology Clinical Practice Guideline Update on the Use of Pharmacologic Interventions Including Tamoxifen, Raloxifene, and Aromatase Inhibition for Breast Cancer Risk Reduction

(2009) Kala Visvanathan et al.   JOURNAL OF CLINICAL ONCOLOGY

Meta-analysis of Risk Reduction Estimates Associated With Risk-Reducing Salpingo-oophorectomy in BRCA1 or BRCA2 Mutation Carriers

(2009) T. R. Rebbeck et al.   JNCI-Journal of the National Cancer Institute

A randomized trial of a breast/ovarian cancer genetic testing decision aid used as a communication aid during genetic counseling

(2008) Claire E. Wakefield et al.   PSYCHO-ONCOLOGY